Project Grant R21DE033128
Award Date
8/12/24
Completion Date
7/31/26
Dollars Obligated
$244K
Federal Agency
National Institute of Dental and Craniofacial Research
Federal Grant Program
93.121
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19104, USA
Similar Awards
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research Federal Grant Program (CFDA 93.121), provides $667,998.00 to Oridivus LLC to test an innovative oral regenerative therapy leveraging immunoregenerative mechanisms. The project aims to compare the efficacy of FTY720 nanofibers versus platelet-rich plasma (PRP) in improving oral wound healing in rodent and porcine animal models. The proposed research...
This Project Grant award, with a total funding amount of $1,705,144.00, was provided by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121). The award's objective is to develop novel therapies that can endogenously stimulate periodontal regeneration, circumventing the need for transplantation of biomaterials or osteogenic tissue. The research aims to 1) identify specific cell surface markers to isolate and...
This federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), provides $1,722,291 to the University of Maryland, Baltimore to develop novel tunable metformin-releasing injectable scaffolds to enhance dental pulp stem cell-based craniofacial bone regeneration. The 5-year project, starting August 1, 2024, aims to test the hypothesis that transplantation of OCT1-expressing dental pulp...
This Project Grant award, provided by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121), will support the development of a bio-inspired scaffold (referred to as "PerioPatch") for regenerating Sharpey's fibers and periodontal tissues. The $588,952 award, effective April 18, 2025 through March 31, 2030, aims to integrate crucial biophysical and biochemical cues into a matrix to guide periodontal...
This Project Grant award, provided by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research Program (CFDA 93.121), aims to advance the understanding of periodontal stem cells and their role in periodontal tissue regeneration. The $557,606 award, granted on April 16, 2025, will enable Harvard Medical School to conduct research to: 1) characterize the properties and activation of periodontal crestal stem cells, 2) determine the...
The National Institute of Dental and Craniofacial Research (NIDCR), part of the Department of Health and Human Services, awarded a $847,000 Project Grant under the Oral Diseases and Disorders Research program (CFDA 93.121) to the University of Utah. The 2-year grant, awarded on August 1, 2023, will fund research to develop and evaluate the efficacy of a novel antimicrobial bone scaffold made from zinc-doped fluorapatite for use in craniofacial surgical applications. The research aims to...
This Project Grant award, with a total funding amount of $215,256.00 and an award date of August 1, 2024, was provided by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research federal grant program (CFDA 93.121). The grant supports research aimed at developing a controlled release system for engineered anti-inflammatory extracellular vesicles (EVs) derived from mesenchymal stem cells (MSCs). The research objectives are to: 1) engineer...
This federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research Federal Grant Program (CFDA 93.121), provides $1 to support a research project titled "ULTRA-HIGH RESOLUTION 3D GENOME MAPS FOR MULTIPLE HUMAN TISSUES." The project aims to accurately map enhancer-promoter interactions across multiple human tissues using advanced experimental and computational techniques. This will enhance existing...
This federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121) totaling $1,493,635 will support Sinopia Biosciences Inc.'s preclinical research to develop a novel small molecule compound for treating radiation-induced oral mucositis. The project aims to advance a lead compound that selectively inhibits a specific target domain to ameliorate the severe side effects of oral inflammation...
This Project Grant award, with Federal Grant ID R35DE034348, was provided by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research Federal Grant Program (CFDA 93.121). The $2,055,996 award supports a research program to investigate skeletal stem cell plasticity as a central mechanism of craniofacial bone formation and disease. The research program aims to address fundamental mechanisms of craniofacial bone diseases from the...